top of page
December 21, 2016
Appili Therapeutics Raises $2.2M in Equity Capital to Develop Its Anti-Infective Pipeline
Read More
October 3, 2016
Appili Therapeutics Inc. Appoints Kimberly Stephens as Chief Financial Officer
Read More
May 25, 2016
Appili Raises $3.2M in Seed Round To Develop Novel Antibiotics
Read More
April 12, 2016
Appili Receives Orphan Drug Designation from FDA for ATI-1501: Treating C. difficile in Children
Read More
bottom of page